+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cough Syrup Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786925
The global cough syrup market attained a value of about USD 5,994.22 million in 2022. The market is expected to grow at a CAGR of 3.8% during the forecast period of 2023-2031 to attain nearly USD 8,398.12 million by 2031. The market growth is likely to be aided by the growing government investment during the forecast period of 2023-2031.

Cough Syrup Market: Introduction

Cough syrup is a type of medicine that is used to treat coughs, either dry or productive (coughs that produce mucus). It is typically a liquid medication that is taken orally, and it contains ingredients that can help to alleviate coughing and soothe the throat.

The active ingredients in cough syrup can vary, but they may include cough suppressants, expectorants, and/or antihistamines. Cough suppressants are used to suppress the cough reflex, while expectorants are used to thin mucus and make it easier to cough up. Antihistamines may be included to help reduce inflammation and irritation in the throat.

Cough syrup can be used to treat various types of coughs, including those associated with the common cold, flu, and bronchitis. It can also be used to treat coughs caused by allergies, asthma, and other respiratory conditions. Additionally, some cough syrups may contain other ingredients such as pain relievers or fever reducers to help alleviate other symptoms associated with coughs.

It is important to follow the recommended dosage and instructions when taking cough syrup, as overuse or misuse can lead to side effects. Additionally, cough syrup may not be appropriate for everyone, particularly those with certain medical conditions or who are taking other medications. It is always best to speak with a healthcare provider before taking any new medication.

Cough Syrup Market Segmentations

Market Breakup by Product Type

  • Expectorants
  • Cough Suppressants
  • Combination Medications
  • Others

Market Breakup by Population Type

  • Paediatric
  • Adults

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel

Cough Syrup Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Cough Syrup Market Scenario

The cough syrup market has been driven by several key factors, including the increasing prevalence of respiratory illnesses, the growing awareness of the benefits of cough syrups, and the availability of over-the-counter (OTC) medications. In recent years, the incidence of respiratory illnesses such as the common cold, flu, and asthma has been on the rise, driving demand for cough syrups as an effective treatment option. Additionally, the growing awareness of the benefits of cough syrup, including its ability to provide relief from coughing and soothe the throat, has led to an increased demand for the product.

The availability of cough syrup as an OTC medication has also contributed to its popularity. Consumers can easily purchase cough syrup without a prescription, making it a convenient option for those who need quick relief from coughing. The development of new formulations and flavours of cough syrup has also driven market growth, as manufacturers seek to offer products that are more appealing and easier to take.

Moreover, the increasing adoption of online retail channels for the sale of cough syrup and other OTC medicines has further driven market growth. The availability of online platforms has made it easier for consumers to purchase cough syrup from the comfort of their homes. The trend of self-medication and growing healthcare awareness among people is expected to fuel the demand for cough syrup in the coming years. As a result, the cough syrup market is expected to continue growing in the foreseeable future.

Key Players in the Global Cough Syrup Market

The report gives an in-depth analysis of the key players involved in the cough syrup market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc
  • Prestige Consumer Healthcare Inc
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cough Syrup Market Overview
3.1 Global Cough Syrup Market Historical Value (2016-2022)
3.2 Global Cough Syrup Market Forecast Value (2023-2031)
4 Global Cough Syrup Market Landscape
4.1 Global Cough Syrup Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cough Syrup Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Drug Type
4.2.3 Analysis by Population type
4.2.4 Analysis by Therapy Type
4.2.5 Analysis by Distribution Channel
5 Global Cough Syrup Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cough Syrup Market Segmentation
6.1 Global Cough Syrup Market by Product Type
6.1.1 Market Overview
6.1.2 Expectorants
6.1.3 Cough Suppressants
6.1.4 Combination Medications
6.1.5 Others
6.2 Global Cough Syrup Market by Population Type
6.2.1 Market Overview
6.2.2 Pediatric
6.2.3 Adults
6.3 Global Cough Syrup Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Channel
6.3.5 Public Channel
6.4 Global Cough Syrup Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cough Syrup Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cough Syrup Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cough Syrup Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cough Syrup Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cough Syrup Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication Year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Acella Pharmaceuticals LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bayer AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GlaxoSmithKline PLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Johnson & Johnson
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Pfizer Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Prestige Consumer Healthcare Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Reckitt Benckiser Group PLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Sanofi
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Sun Pharmaceutical Industries Limited
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 The Procter & Gamble Company
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Cough Syrup Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company

Methodology

Loading
LOADING...

Table Information